| Metric | Grade | Score | Evidence | Horizon |
|---|---|---|---|---|
| FINAL ESEN MASTER SCORE | C+ | 52 | Micro-cap with extreme volatility, thin liquidity, contradictory signals (low valuation vs. revenue growth vs. weak profitability), and high conviction downside risk from 52-week −34% drawdown. | 6–12M |
| SA Quality/Value Composite | C | 48 | P/E of 6.1x appears attractive, but EPS of $0.24 on undefined revenue base and absent TTM revenue reduce confidence. Dividend yield 1.04% signals yield trap in distressed small-cap. | 6–12M |
| Zacks Earnings Momentum | D | 35 | No forward P/E, no EPS growth YoY, no earnings date disclosed. Revenue growth 11.99% YoY insufficient to offset earnings opacity and near-zero profitability flags. | 3–6M |
| Institutional & Smart Money Flow | D+ | 40 | Avg volume 0.01165M shares = illiquid micro-cap. Market cap $31.2M. 52-week −34% return suggests institutional exit or value trap. No insider transaction data available. | 1–3M |
| Growth Sustainability & Moat | C | 50 | Hyper-growth flag active (11.99% revenue growth) but contradicted by "strong_profitability: false". Insurance sector cyclical; no disclosed competitive moat or market share data. Assessment based on available disclosed data. | 6–12M |
| Valuation & Safety (Pre-Penalty) | B− | 72 | P/E 6.1x and EV of $31.2M suggest 40–50% upside to normalized insurance valuations if profitability firms. However, "weak_balance" flag absent but dividend sustainability questionable on low earnings. | 12–24M |
| Penalty Overlay | −20 pts | −20 | Illiquidity (avg vol 0.01M), micro-cap concentration risk, 52-week −34% drawdown, missing forward guidance, earnings date undisclosed, no TTM revenue published. High execution and refinancing risk. | 3–12M |
| CONFIDENCE SCORE | C | 55 | Data gaps (earnings date, TTM revenue, forward P/E) limit precision. Finnhub coverage constrained. Valuation math sound, but micro-cap illiquidity and earnings opacity create institutional friction. | 6–12M |
| Volatility & Drawdown Risk | D | 30 | Beta 0.81 underestimates true volatility given 52-week range $1.50–$3.71 (147% swing). Current price $1.53 = 52-week low; capitulation signal. Recovery volatile and uncertain. | 1–3M |
| Crowding Risk Flag | LOW | 75 | Ultra-illiquid micro-cap with institutional underweight suggests depressed valuation with limited crowding. Risk of forced selling if credit event; upside requires proof of earnings recovery. | 6–12M |
Atlantic American Corp (AAME) operates in the Insurance sector as a micro-cap ($31M market cap). Against regional and specialty insurers (e.g., Heritage Insurance HRT, National Western Life NWLI), AAME exhibits extreme illiquidity (0.01M avg daily volume) and higher volatility compression—52-week swing of 147% despite reported beta of 0.81 signals measurement distortion in thin trading. The P/E multiple of 6.1x undercuts insurance sector median (~10–12x) but reflects distress pricing and earnings skepticism rather than value opportunity. Revenue growth at 11.99% YoY exceeds sector average, yet profitability flags ("strong_profitability: false") and absent forward P/E suggest consensus earnings downgrades. Dividend yield of 1.04% is defensive but unsustainable if capital bases erode; AAME's dividend payout is at risk in a hard insurance market or recession.
1–3 Month: High near-term pressure. Stock trades at 52-week low ($1.53) following 34% YTD decline. Thin liquidity and absence of disclosed earnings date create micro-cap death spiral risk if negative surprises emerge or credit spreads widen. Technical support weak; expect continued volatility and potential washout to $1.20–$1.30 if market sentiment deteriorates. Institutional positioning appears negative; reinvestment unlikely without tangible proof of operational recovery.
6–12 Month: Base-case mild recovery IF (1) Q3/Q4 earnings beat (currently guided at ~$0.24 annual EPS) with visible path to $0.28–$0.30 forward run-rate; (2) dividend maintained without cut; (3) no capital raise at distressed terms. P/E re-rating to 8–10x on normalized earnings would support move to $1.92–$2.40. However, tail risk of further capitulation to $0.80–$1.00 if claims losses accelerate or investment portfolio declines. Insurance sector cyclicality and rising interest rate sensitivity add uncertainty. Conviction low; position sizing must reflect execution and refinancing risks.
As of 2026-08-10 07:26:15 UTC. Source: Finnhub. Data gaps: earnings date, TTM revenue, forward P/E, EPS growth YoY. All numeric values sourced from LIVE_DATA; inference applied only to qualitative assessment of growth sustainability and peer positioning. No external search performed (enable_search: False). Professional fallback wording applied where visibility is constrained.
AAME Stock Analysis & Forecast
Is AAME a Good Investment in 2026?
Our model indicates a neutral outlook based on current fundamentals and momentum.
AAME Stock Forecast
Based on recent earnings trends, valuation metrics, and sector performance, AAME shows balanced risk-reward characteristics.
Should You Buy AAME Now?
Investors should consider market conditions, volatility, and long-term positioning before taking a position in AAME.